Robert Quinn

Pharnext SA develops and manufactures drugs for neurological diseases. Its products include R&D Pipeline, PXT3003, and PXT864 are used for the treatment of Charcot-Marie-Tooth disease, diabetic, and toxic peripheral neuropathies, as well as severe neurodegenerative diseases in general and peripheral neuropathies. The company was founded in 2007 by Daniel Cohen, Loic Heidsieck, Serguei Nabirotchkine, Oxana Guerassimenko and Ilya Chumakov and is headquartered in Paris, France.

BenevolentAI SA is a holding company, which engages in the research and development and sale of AI-enabled drugs. Its business platform combines artificial intelligence and machine learning in discovering medicines. It operates through the UK and Europe geographical segments. The company was founded by Ivan Griffin, Kenneth Patrick Mulvany, and Michael Brennan in November 2013 and is headquartered in London, the United Kingdom.

The Institute of Chartered Accountants in England & Wales is based in London, UK, and has subsidiaries in the UK. The institute operates independently of its membership activities and takes necessary steps to enforce these standards. With over 150,000 members, the institute provides resources such as technical information, helplines, and communities to its members. The Institute of Chartered Accountants in England & Wales, founded in 1880, protects the public interest by ensuring that its firms, members, students, and affiliates maintain the highest standards of professional competency and conduct.